Pradaxa® for the treatment and prevention of DVT and PE
This episode examines 'Pradaxa® for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)' as Professor Samuel Goldhaber (Professor of Medicine, Harvard Medical School, United States) discusses:
How Pradaxa® works in the treatment of and prevention from DVT and PE in patients
The clinical evidence to support the use of Pradaxa® to treat and prevent DVT and PE:
- RE-MEDY™ trial
- RE-SONATE™ trial
- RE-COVER™ I+II pooled analysis